nodes	percent_of_prediction	percent_of_DWPC	metapath
Eprosartan—ABCC2—Verapamil—migraine	0.251	0.466	CbGbCtD
Eprosartan—CYP2C9—Amitriptyline—migraine	0.106	0.197	CbGbCtD
Eprosartan—CYP2C9—Valproic Acid—migraine	0.0968	0.18	CbGbCtD
Eprosartan—CYP2C9—Verapamil—migraine	0.0843	0.157	CbGbCtD
Eprosartan—Losartan—ACE—migraine	0.00469	1	CrCbGaD
Eprosartan—AGTR1—ACE Inhibitor Pathway—ACE—migraine	0.00318	0.0978	CbGpPWpGaD
Eprosartan—AGTR1—Peptide GPCRs—EDNRA—migraine	0.00104	0.0319	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—HTR2B—migraine	0.000838	0.0258	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2B—migraine	0.00075	0.0231	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000697	0.0215	CbGpPWpGaD
Eprosartan—Body temperature increased—Propranolol—migraine	0.000678	0.0016	CcSEcCtD
Eprosartan—Abdominal pain—Propranolol—migraine	0.000678	0.0016	CcSEcCtD
Eprosartan—Visual impairment—Timolol—migraine	0.000675	0.00159	CcSEcCtD
Eprosartan—Flatulence—Valproic Acid—migraine	0.000675	0.00159	CcSEcCtD
Eprosartan—Pain—Verapamil—migraine	0.000674	0.00159	CcSEcCtD
Eprosartan—Constipation—Verapamil—migraine	0.000674	0.00159	CcSEcCtD
Eprosartan—Tension—Valproic Acid—migraine	0.000672	0.00158	CcSEcCtD
Eprosartan—Vomiting—Amitriptyline—migraine	0.000669	0.00158	CcSEcCtD
Eprosartan—Sweating increased—Topiramate—migraine	0.000668	0.00157	CcSEcCtD
Eprosartan—Angina pectoris—Topiramate—migraine	0.000668	0.00157	CcSEcCtD
Eprosartan—Nervousness—Valproic Acid—migraine	0.000665	0.00157	CcSEcCtD
Eprosartan—Bradycardia—Gabapentin—migraine	0.000664	0.00156	CcSEcCtD
Eprosartan—Rash—Amitriptyline—migraine	0.000664	0.00156	CcSEcCtD
Eprosartan—Dermatitis—Amitriptyline—migraine	0.000663	0.00156	CcSEcCtD
Eprosartan—Back pain—Valproic Acid—migraine	0.000663	0.00156	CcSEcCtD
Eprosartan—Headache—Amitriptyline—migraine	0.00066	0.00155	CcSEcCtD
Eprosartan—Bronchitis—Topiramate—migraine	0.000659	0.00155	CcSEcCtD
Eprosartan—Muscle spasms—Valproic Acid—migraine	0.000659	0.00155	CcSEcCtD
Eprosartan—Rhinitis—Gabapentin—migraine	0.000654	0.00154	CcSEcCtD
Eprosartan—Tinnitus—Timolol—migraine	0.000653	0.00154	CcSEcCtD
Eprosartan—Feeling abnormal—Verapamil—migraine	0.00065	0.00153	CcSEcCtD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000648	0.02	CbGpPWpGaD
Eprosartan—Pharyngitis—Gabapentin—migraine	0.000647	0.00153	CcSEcCtD
Eprosartan—Oedema peripheral—Gabapentin—migraine	0.000643	0.00151	CcSEcCtD
Eprosartan—Tremor—Valproic Acid—migraine	0.000642	0.00151	CcSEcCtD
Eprosartan—Upper respiratory tract infection—Topiramate—migraine	0.000637	0.0015	CcSEcCtD
Eprosartan—Ill-defined disorder—Valproic Acid—migraine	0.000636	0.0015	CcSEcCtD
Eprosartan—Pollakiuria—Topiramate—migraine	0.000633	0.00149	CcSEcCtD
Eprosartan—Hypersensitivity—Propranolol—migraine	0.000632	0.00149	CcSEcCtD
Eprosartan—Visual impairment—Gabapentin—migraine	0.000629	0.00148	CcSEcCtD
Eprosartan—Urticaria—Verapamil—migraine	0.000626	0.00148	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—CALCRL—migraine	0.000626	0.0193	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—RAMP1—migraine	0.000626	0.0193	CbGpPWpGaD
Eprosartan—Angioedema—Valproic Acid—migraine	0.000626	0.00147	CcSEcCtD
Eprosartan—Nausea—Amitriptyline—migraine	0.000625	0.00147	CcSEcCtD
Eprosartan—Hyperglycaemia—Topiramate—migraine	0.000619	0.00146	CcSEcCtD
Eprosartan—Malaise—Valproic Acid—migraine	0.000618	0.00146	CcSEcCtD
Eprosartan—Vertigo—Valproic Acid—migraine	0.000615	0.00145	CcSEcCtD
Eprosartan—Asthenia—Propranolol—migraine	0.000615	0.00145	CcSEcCtD
Eprosartan—Depression—Topiramate—migraine	0.00061	0.00144	CcSEcCtD
Eprosartan—Tinnitus—Gabapentin—migraine	0.000608	0.00143	CcSEcCtD
Eprosartan—Palpitations—Valproic Acid—migraine	0.000605	0.00143	CcSEcCtD
Eprosartan—Renal failure—Topiramate—migraine	0.000601	0.00142	CcSEcCtD
Eprosartan—Neuropathy peripheral—Topiramate—migraine	0.000599	0.00141	CcSEcCtD
Eprosartan—Tension—Timolol—migraine	0.000598	0.00141	CcSEcCtD
Eprosartan—Cough—Valproic Acid—migraine	0.000598	0.00141	CcSEcCtD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000597	0.0184	CbGpPWpGaD
Eprosartan—Urinary tract infection—Topiramate—migraine	0.000594	0.0014	CcSEcCtD
Eprosartan—Conjunctivitis—Topiramate—migraine	0.000594	0.0014	CcSEcCtD
Eprosartan—Nervousness—Timolol—migraine	0.000592	0.0014	CcSEcCtD
Eprosartan—Diarrhoea—Propranolol—migraine	0.000587	0.00138	CcSEcCtD
Eprosartan—Chills—Gabapentin—migraine	0.000585	0.00138	CcSEcCtD
Eprosartan—Arthralgia—Valproic Acid—migraine	0.000583	0.00137	CcSEcCtD
Eprosartan—Chest pain—Valproic Acid—migraine	0.000583	0.00137	CcSEcCtD
Eprosartan—Myalgia—Valproic Acid—migraine	0.000583	0.00137	CcSEcCtD
Eprosartan—Haematuria—Topiramate—migraine	0.000583	0.00137	CcSEcCtD
Eprosartan—Anxiety—Valproic Acid—migraine	0.000581	0.00137	CcSEcCtD
Eprosartan—Hypersensitivity—Verapamil—migraine	0.000581	0.00137	CcSEcCtD
Eprosartan—Epistaxis—Topiramate—migraine	0.000577	0.00136	CcSEcCtD
Eprosartan—Discomfort—Valproic Acid—migraine	0.000576	0.00136	CcSEcCtD
Eprosartan—Sinusitis—Topiramate—migraine	0.000574	0.00135	CcSEcCtD
Eprosartan—Dry mouth—Valproic Acid—migraine	0.00057	0.00134	CcSEcCtD
Eprosartan—Dizziness—Propranolol—migraine	0.000567	0.00134	CcSEcCtD
Eprosartan—Asthenia—Verapamil—migraine	0.000566	0.00133	CcSEcCtD
Eprosartan—Flatulence—Gabapentin—migraine	0.00056	0.00132	CcSEcCtD
Eprosartan—Bradycardia—Topiramate—migraine	0.000559	0.00132	CcSEcCtD
Eprosartan—Pruritus—Verapamil—migraine	0.000558	0.00131	CcSEcCtD
Eprosartan—Tension—Gabapentin—migraine	0.000557	0.00131	CcSEcCtD
Eprosartan—Angioedema—Timolol—migraine	0.000557	0.00131	CcSEcCtD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000555	0.0171	CbGpPWpGaD
Eprosartan—Nervousness—Gabapentin—migraine	0.000552	0.0013	CcSEcCtD
Eprosartan—Rhinitis—Topiramate—migraine	0.00055	0.0013	CcSEcCtD
Eprosartan—Back pain—Gabapentin—migraine	0.000549	0.00129	CcSEcCtD
Eprosartan—Vertigo—Timolol—migraine	0.000548	0.00129	CcSEcCtD
Eprosartan—Thrombocytopenia—Valproic Acid—migraine	0.000547	0.00129	CcSEcCtD
Eprosartan—Syncope—Timolol—migraine	0.000547	0.00129	CcSEcCtD
Eprosartan—Muscle spasms—Gabapentin—migraine	0.000546	0.00129	CcSEcCtD
Eprosartan—Tachycardia—Valproic Acid—migraine	0.000546	0.00129	CcSEcCtD
Eprosartan—Vomiting—Propranolol—migraine	0.000545	0.00128	CcSEcCtD
Eprosartan—Pharyngitis—Topiramate—migraine	0.000545	0.00128	CcSEcCtD
Eprosartan—Oedema peripheral—Topiramate—migraine	0.000541	0.00127	CcSEcCtD
Eprosartan—Hyperhidrosis—Valproic Acid—migraine	0.00054	0.00127	CcSEcCtD
Eprosartan—Rash—Propranolol—migraine	0.00054	0.00127	CcSEcCtD
Eprosartan—Dermatitis—Propranolol—migraine	0.00054	0.00127	CcSEcCtD
Eprosartan—Diarrhoea—Verapamil—migraine	0.00054	0.00127	CcSEcCtD
Eprosartan—Palpitations—Timolol—migraine	0.000539	0.00127	CcSEcCtD
Eprosartan—Loss of consciousness—Timolol—migraine	0.000536	0.00126	CcSEcCtD
Eprosartan—Anorexia—Valproic Acid—migraine	0.000533	0.00126	CcSEcCtD
Eprosartan—Cough—Timolol—migraine	0.000532	0.00125	CcSEcCtD
Eprosartan—Tremor—Gabapentin—migraine	0.000532	0.00125	CcSEcCtD
Eprosartan—Visual impairment—Topiramate—migraine	0.000529	0.00125	CcSEcCtD
Eprosartan—Ill-defined disorder—Gabapentin—migraine	0.000527	0.00124	CcSEcCtD
Eprosartan—Hypotension—Valproic Acid—migraine	0.000522	0.00123	CcSEcCtD
Eprosartan—Dizziness—Verapamil—migraine	0.000521	0.00123	CcSEcCtD
Eprosartan—Arthralgia—Timolol—migraine	0.000519	0.00122	CcSEcCtD
Eprosartan—Myalgia—Timolol—migraine	0.000519	0.00122	CcSEcCtD
Eprosartan—Chest pain—Timolol—migraine	0.000519	0.00122	CcSEcCtD
Eprosartan—Angioedema—Gabapentin—migraine	0.000519	0.00122	CcSEcCtD
Eprosartan—AGTR1—G alpha (q) signalling events—TAC1—migraine	0.000518	0.016	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—NPS—migraine	0.000518	0.016	CbGpPWpGaD
Eprosartan—Anxiety—Timolol—migraine	0.000517	0.00122	CcSEcCtD
Eprosartan—Discomfort—Timolol—migraine	0.000513	0.00121	CcSEcCtD
Eprosartan—Malaise—Gabapentin—migraine	0.000512	0.00121	CcSEcCtD
Eprosartan—Tinnitus—Topiramate—migraine	0.000512	0.00121	CcSEcCtD
Eprosartan—AGTR1—Peptide ligand-binding receptors—NPS—migraine	0.000511	0.0158	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—TAC1—migraine	0.000511	0.0158	CbGpPWpGaD
Eprosartan—Vertigo—Gabapentin—migraine	0.00051	0.0012	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Valproic Acid—migraine	0.000509	0.0012	CcSEcCtD
Eprosartan—Syncope—Gabapentin—migraine	0.000509	0.0012	CcSEcCtD
Eprosartan—Nausea—Propranolol—migraine	0.000509	0.0012	CcSEcCtD
Eprosartan—AGTR1—G alpha (q) signalling events—HTR2C—migraine	0.000508	0.0156	CbGpPWpGaD
Eprosartan—Dry mouth—Timolol—migraine	0.000508	0.0012	CcSEcCtD
Eprosartan—Insomnia—Valproic Acid—migraine	0.000506	0.00119	CcSEcCtD
Eprosartan—Paraesthesia—Valproic Acid—migraine	0.000502	0.00118	CcSEcCtD
Eprosartan—Palpitations—Gabapentin—migraine	0.000502	0.00118	CcSEcCtD
Eprosartan—Vomiting—Verapamil—migraine	0.000501	0.00118	CcSEcCtD
Eprosartan—Loss of consciousness—Gabapentin—migraine	0.000499	0.00118	CcSEcCtD
Eprosartan—Dyspnoea—Valproic Acid—migraine	0.000498	0.00117	CcSEcCtD
Eprosartan—Rash—Verapamil—migraine	0.000497	0.00117	CcSEcCtD
Eprosartan—Somnolence—Valproic Acid—migraine	0.000497	0.00117	CcSEcCtD
Eprosartan—Dermatitis—Verapamil—migraine	0.000497	0.00117	CcSEcCtD
Eprosartan—Cough—Gabapentin—migraine	0.000496	0.00117	CcSEcCtD
Eprosartan—AGTR1—G alpha (q) signalling events—EDNRA—migraine	0.000494	0.0152	CbGpPWpGaD
Eprosartan—Headache—Verapamil—migraine	0.000494	0.00116	CcSEcCtD
Eprosartan—Chills—Topiramate—migraine	0.000492	0.00116	CcSEcCtD
Eprosartan—Dyspepsia—Valproic Acid—migraine	0.000492	0.00116	CcSEcCtD
Eprosartan—Shock—Timolol—migraine	0.00049	0.00115	CcSEcCtD
Eprosartan—AGTR1—Peptide ligand-binding receptors—EDNRA—migraine	0.000488	0.015	CbGpPWpGaD
Eprosartan—Decreased appetite—Valproic Acid—migraine	0.000486	0.00114	CcSEcCtD
Eprosartan—Arthralgia—Gabapentin—migraine	0.000483	0.00114	CcSEcCtD
Eprosartan—Myalgia—Gabapentin—migraine	0.000483	0.00114	CcSEcCtD
Eprosartan—Chest pain—Gabapentin—migraine	0.000483	0.00114	CcSEcCtD
Eprosartan—Fatigue—Valproic Acid—migraine	0.000482	0.00114	CcSEcCtD
Eprosartan—Anxiety—Gabapentin—migraine	0.000482	0.00114	CcSEcCtD
Eprosartan—Hyperhidrosis—Timolol—migraine	0.000481	0.00113	CcSEcCtD
Eprosartan—Pain—Valproic Acid—migraine	0.000478	0.00113	CcSEcCtD
Eprosartan—Constipation—Valproic Acid—migraine	0.000478	0.00113	CcSEcCtD
Eprosartan—Discomfort—Gabapentin—migraine	0.000478	0.00113	CcSEcCtD
Eprosartan—Anorexia—Timolol—migraine	0.000474	0.00112	CcSEcCtD
Eprosartan—Dry mouth—Gabapentin—migraine	0.000473	0.00111	CcSEcCtD
Eprosartan—Flatulence—Topiramate—migraine	0.000471	0.00111	CcSEcCtD
Eprosartan—Tension—Topiramate—migraine	0.000469	0.0011	CcSEcCtD
Eprosartan—Nausea—Verapamil—migraine	0.000468	0.0011	CcSEcCtD
Eprosartan—Hypotension—Timolol—migraine	0.000465	0.0011	CcSEcCtD
Eprosartan—Nervousness—Topiramate—migraine	0.000464	0.00109	CcSEcCtD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.000463	0.0143	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.000463	0.0143	CbGpPWpGaD
Eprosartan—Back pain—Topiramate—migraine	0.000462	0.00109	CcSEcCtD
Eprosartan—Feeling abnormal—Valproic Acid—migraine	0.000461	0.00109	CcSEcCtD
Eprosartan—Muscle spasms—Topiramate—migraine	0.000459	0.00108	CcSEcCtD
Eprosartan—Gastrointestinal pain—Valproic Acid—migraine	0.000457	0.00108	CcSEcCtD
Eprosartan—Shock—Gabapentin—migraine	0.000456	0.00107	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—HTR1D—migraine	0.000455	0.014	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.000454	0.014	CbGpPWpGaD
Eprosartan—Thrombocytopenia—Gabapentin—migraine	0.000454	0.00107	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Timolol—migraine	0.000453	0.00107	CcSEcCtD
Eprosartan—Tachycardia—Gabapentin—migraine	0.000452	0.00107	CcSEcCtD
Eprosartan—Insomnia—Timolol—migraine	0.00045	0.00106	CcSEcCtD
Eprosartan—Hyperhidrosis—Gabapentin—migraine	0.000448	0.00106	CcSEcCtD
Eprosartan—Tremor—Topiramate—migraine	0.000448	0.00105	CcSEcCtD
Eprosartan—Paraesthesia—Timolol—migraine	0.000447	0.00105	CcSEcCtD
Eprosartan—Urticaria—Valproic Acid—migraine	0.000444	0.00105	CcSEcCtD
Eprosartan—Dyspnoea—Timolol—migraine	0.000444	0.00105	CcSEcCtD
Eprosartan—Ill-defined disorder—Topiramate—migraine	0.000443	0.00104	CcSEcCtD
Eprosartan—Somnolence—Timolol—migraine	0.000442	0.00104	CcSEcCtD
Eprosartan—Abdominal pain—Valproic Acid—migraine	0.000442	0.00104	CcSEcCtD
Eprosartan—Body temperature increased—Valproic Acid—migraine	0.000442	0.00104	CcSEcCtD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.000442	0.0136	CbGpPWpGaD
Eprosartan—Anorexia—Gabapentin—migraine	0.000442	0.00104	CcSEcCtD
Eprosartan—Dyspepsia—Timolol—migraine	0.000438	0.00103	CcSEcCtD
Eprosartan—Hypotension—Gabapentin—migraine	0.000433	0.00102	CcSEcCtD
Eprosartan—Decreased appetite—Timolol—migraine	0.000433	0.00102	CcSEcCtD
Eprosartan—Malaise—Topiramate—migraine	0.000431	0.00102	CcSEcCtD
Eprosartan—Vertigo—Topiramate—migraine	0.000429	0.00101	CcSEcCtD
Eprosartan—Fatigue—Timolol—migraine	0.000429	0.00101	CcSEcCtD
Eprosartan—Syncope—Topiramate—migraine	0.000428	0.00101	CcSEcCtD
Eprosartan—Pain—Timolol—migraine	0.000426	0.001	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—HTR2B—migraine	0.000423	0.013	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000422	0.013	CbGpPWpGaD
Eprosartan—Musculoskeletal discomfort—Gabapentin—migraine	0.000422	0.000995	CcSEcCtD
Eprosartan—Palpitations—Topiramate—migraine	0.000422	0.000995	CcSEcCtD
Eprosartan—Loss of consciousness—Topiramate—migraine	0.00042	0.000989	CcSEcCtD
Eprosartan—Insomnia—Gabapentin—migraine	0.000419	0.000988	CcSEcCtD
Eprosartan—ABCC2—Transmembrane transport of small molecules—TRPM8—migraine	0.000418	0.0129	CbGpPWpGaD
Eprosartan—Cough—Topiramate—migraine	0.000417	0.000982	CcSEcCtD
Eprosartan—Paraesthesia—Gabapentin—migraine	0.000416	0.00098	CcSEcCtD
Eprosartan—Dyspnoea—Gabapentin—migraine	0.000413	0.000973	CcSEcCtD
Eprosartan—Somnolence—Gabapentin—migraine	0.000412	0.000971	CcSEcCtD
Eprosartan—Hypersensitivity—Valproic Acid—migraine	0.000412	0.00097	CcSEcCtD
Eprosartan—Feeling abnormal—Timolol—migraine	0.00041	0.000966	CcSEcCtD
Eprosartan—Dyspepsia—Gabapentin—migraine	0.000408	0.000961	CcSEcCtD
Eprosartan—Gastrointestinal pain—Timolol—migraine	0.000407	0.000959	CcSEcCtD
Eprosartan—Chest pain—Topiramate—migraine	0.000407	0.000958	CcSEcCtD
Eprosartan—Myalgia—Topiramate—migraine	0.000407	0.000958	CcSEcCtD
Eprosartan—Arthralgia—Topiramate—migraine	0.000407	0.000958	CcSEcCtD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000407	0.0125	CbGpPWpGaD
Eprosartan—Anxiety—Topiramate—migraine	0.000405	0.000955	CcSEcCtD
Eprosartan—Decreased appetite—Gabapentin—migraine	0.000403	0.000949	CcSEcCtD
Eprosartan—Discomfort—Topiramate—migraine	0.000402	0.000947	CcSEcCtD
Eprosartan—Asthenia—Valproic Acid—migraine	0.000401	0.000945	CcSEcCtD
Eprosartan—Fatigue—Gabapentin—migraine	0.0004	0.000941	CcSEcCtD
Eprosartan—Dry mouth—Topiramate—migraine	0.000398	0.000937	CcSEcCtD
Eprosartan—Pain—Gabapentin—migraine	0.000396	0.000934	CcSEcCtD
Eprosartan—Constipation—Gabapentin—migraine	0.000396	0.000934	CcSEcCtD
Eprosartan—Pruritus—Valproic Acid—migraine	0.000396	0.000932	CcSEcCtD
Eprosartan—Urticaria—Timolol—migraine	0.000395	0.000931	CcSEcCtD
Eprosartan—Abdominal pain—Timolol—migraine	0.000393	0.000927	CcSEcCtD
Eprosartan—Body temperature increased—Timolol—migraine	0.000393	0.000927	CcSEcCtD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000393	0.0121	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—SLC6A4—migraine	0.000387	0.0119	CbGpPWpGaD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—migraine	0.000385	0.0119	CbGpPWpGaD
Eprosartan—Shock—Topiramate—migraine	0.000384	0.000904	CcSEcCtD
Eprosartan—Diarrhoea—Valproic Acid—migraine	0.000383	0.000901	CcSEcCtD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000382	0.0118	CbGpPWpGaD
Eprosartan—Feeling abnormal—Gabapentin—migraine	0.000382	0.0009	CcSEcCtD
Eprosartan—Thrombocytopenia—Topiramate—migraine	0.000382	0.000899	CcSEcCtD
Eprosartan—Tachycardia—Topiramate—migraine	0.000381	0.000897	CcSEcCtD
Eprosartan—Gastrointestinal pain—Gabapentin—migraine	0.000379	0.000893	CcSEcCtD
Eprosartan—Hyperhidrosis—Topiramate—migraine	0.000377	0.000888	CcSEcCtD
Eprosartan—Anorexia—Topiramate—migraine	0.000372	0.000876	CcSEcCtD
Eprosartan—Dizziness—Valproic Acid—migraine	0.00037	0.000871	CcSEcCtD
Eprosartan—Urticaria—Gabapentin—migraine	0.000368	0.000867	CcSEcCtD
Eprosartan—Hypersensitivity—Timolol—migraine	0.000367	0.000864	CcSEcCtD
Eprosartan—Abdominal pain—Gabapentin—migraine	0.000366	0.000863	CcSEcCtD
Eprosartan—Body temperature increased—Gabapentin—migraine	0.000366	0.000863	CcSEcCtD
Eprosartan—Hypotension—Topiramate—migraine	0.000364	0.000858	CcSEcCtD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000362	0.0111	CbGpPWpGaD
Eprosartan—Asthenia—Timolol—migraine	0.000357	0.000841	CcSEcCtD
Eprosartan—Vomiting—Valproic Acid—migraine	0.000355	0.000837	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Topiramate—migraine	0.000355	0.000837	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—CALCRL—migraine	0.000354	0.0109	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—RAMP1—migraine	0.000354	0.0109	CbGpPWpGaD
Eprosartan—Insomnia—Topiramate—migraine	0.000353	0.000831	CcSEcCtD
Eprosartan—Rash—Valproic Acid—migraine	0.000353	0.00083	CcSEcCtD
Eprosartan—Dermatitis—Valproic Acid—migraine	0.000352	0.00083	CcSEcCtD
Eprosartan—Pruritus—Timolol—migraine	0.000352	0.00083	CcSEcCtD
Eprosartan—Headache—Valproic Acid—migraine	0.00035	0.000825	CcSEcCtD
Eprosartan—Paraesthesia—Topiramate—migraine	0.00035	0.000825	CcSEcCtD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000348	0.0107	CbGpPWpGaD
Eprosartan—Dyspnoea—Topiramate—migraine	0.000348	0.000819	CcSEcCtD
Eprosartan—Somnolence—Topiramate—migraine	0.000347	0.000817	CcSEcCtD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000344	0.0106	CbGpPWpGaD
Eprosartan—Dyspepsia—Topiramate—migraine	0.000343	0.000809	CcSEcCtD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000343	0.0106	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000343	0.0106	CbGpPWpGaD
Eprosartan—Hypersensitivity—Gabapentin—migraine	0.000341	0.000804	CcSEcCtD
Eprosartan—Diarrhoea—Timolol—migraine	0.000341	0.000802	CcSEcCtD
Eprosartan—Decreased appetite—Topiramate—migraine	0.000339	0.000799	CcSEcCtD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000336	0.0104	CbGpPWpGaD
Eprosartan—Fatigue—Topiramate—migraine	0.000336	0.000792	CcSEcCtD
Eprosartan—Constipation—Topiramate—migraine	0.000333	0.000786	CcSEcCtD
Eprosartan—Pain—Topiramate—migraine	0.000333	0.000786	CcSEcCtD
Eprosartan—Asthenia—Gabapentin—migraine	0.000333	0.000783	CcSEcCtD
Eprosartan—Nausea—Valproic Acid—migraine	0.000332	0.000782	CcSEcCtD
Eprosartan—Dizziness—Timolol—migraine	0.000329	0.000775	CcSEcCtD
Eprosartan—Pruritus—Gabapentin—migraine	0.000328	0.000773	CcSEcCtD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000327	0.0101	CbGpPWpGaD
Eprosartan—Feeling abnormal—Topiramate—migraine	0.000321	0.000757	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—CALCRL—migraine	0.000321	0.00989	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—RAMP1—migraine	0.000321	0.00989	CbGpPWpGaD
Eprosartan—Gastrointestinal pain—Topiramate—migraine	0.000319	0.000751	CcSEcCtD
Eprosartan—Diarrhoea—Gabapentin—migraine	0.000317	0.000747	CcSEcCtD
Eprosartan—ABCC2—Transmembrane transport of small molecules—ATP1A3—migraine	0.000317	0.00976	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—ATP1A2—migraine	0.000317	0.00976	CbGpPWpGaD
Eprosartan—Vomiting—Timolol—migraine	0.000316	0.000746	CcSEcCtD
Eprosartan—Rash—Timolol—migraine	0.000314	0.000739	CcSEcCtD
Eprosartan—Dermatitis—Timolol—migraine	0.000314	0.000739	CcSEcCtD
Eprosartan—Headache—Timolol—migraine	0.000312	0.000735	CcSEcCtD
Eprosartan—AGTR1—G alpha (q) signalling events—HTR2A—migraine	0.000312	0.0096	CbGpPWpGaD
Eprosartan—Urticaria—Topiramate—migraine	0.00031	0.00073	CcSEcCtD
Eprosartan—Abdominal pain—Topiramate—migraine	0.000308	0.000726	CcSEcCtD
Eprosartan—Body temperature increased—Topiramate—migraine	0.000308	0.000726	CcSEcCtD
Eprosartan—Dizziness—Gabapentin—migraine	0.000306	0.000722	CcSEcCtD
Eprosartan—Nausea—Timolol—migraine	0.000296	0.000696	CcSEcCtD
Eprosartan—Vomiting—Gabapentin—migraine	0.000295	0.000694	CcSEcCtD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000295	0.00907	CbGpPWpGaD
Eprosartan—Rash—Gabapentin—migraine	0.000292	0.000688	CcSEcCtD
Eprosartan—Dermatitis—Gabapentin—migraine	0.000292	0.000688	CcSEcCtD
Eprosartan—ABCC2—NRF2 pathway—TGFBR2—migraine	0.000292	0.00898	CbGpPWpGaD
Eprosartan—Headache—Gabapentin—migraine	0.00029	0.000684	CcSEcCtD
Eprosartan—Hypersensitivity—Topiramate—migraine	0.000287	0.000677	CcSEcCtD
Eprosartan—Asthenia—Topiramate—migraine	0.00028	0.000659	CcSEcCtD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.000279	0.00858	CbGpPWpGaD
Eprosartan—Pruritus—Topiramate—migraine	0.000276	0.00065	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—HTR1B—migraine	0.000276	0.00849	CbGpPWpGaD
Eprosartan—Nausea—Gabapentin—migraine	0.000275	0.000649	CcSEcCtD
Eprosartan—ABCC2—Transmembrane transport of small molecules—HTR3A—migraine	0.00027	0.0083	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—TNF—migraine	0.000267	0.00822	CbGpPWpGaD
Eprosartan—Diarrhoea—Topiramate—migraine	0.000267	0.000629	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—HTR1A—migraine	0.000265	0.00817	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—TAC1—migraine	0.000261	0.00805	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—NPS—migraine	0.000261	0.00805	CbGpPWpGaD
Eprosartan—Dizziness—Topiramate—migraine	0.000258	0.000607	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—HTR1D—migraine	0.000257	0.00792	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—HTR2C—migraine	0.000256	0.00789	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—EDNRA—migraine	0.000249	0.00767	CbGpPWpGaD
Eprosartan—Vomiting—Topiramate—migraine	0.000248	0.000584	CcSEcCtD
Eprosartan—Rash—Topiramate—migraine	0.000246	0.000579	CcSEcCtD
Eprosartan—Dermatitis—Topiramate—migraine	0.000246	0.000579	CcSEcCtD
Eprosartan—Headache—Topiramate—migraine	0.000244	0.000575	CcSEcCtD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000241	0.00742	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CALCA—migraine	0.00024	0.00739	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—HTR2B—migraine	0.000239	0.00736	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—HTR1D—migraine	0.000233	0.00719	CbGpPWpGaD
Eprosartan—Nausea—Topiramate—migraine	0.000232	0.000546	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—HTR7—migraine	0.000224	0.00691	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—HTR2B—migraine	0.000217	0.00668	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000206	0.00636	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—RAMP1—migraine	0.00019	0.00584	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CALCRL—migraine	0.00019	0.00584	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—HTR2A—migraine	0.000157	0.00484	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—HTR1B—migraine	0.000156	0.0048	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—HTR1A—migraine	0.00015	0.00462	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—TAC1—migraine	0.000148	0.00455	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—NPS—migraine	0.000148	0.00455	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—HTR2C—migraine	0.000145	0.00446	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—HTR1B—migraine	0.000141	0.00436	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—EDNRA—migraine	0.000141	0.00434	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HTR1D—migraine	0.000138	0.00425	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—HTR1A—migraine	0.000136	0.00419	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CALCA—migraine	0.000136	0.00417	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—TAC1—migraine	0.000134	0.00413	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—NPS—migraine	0.000134	0.00413	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—HTR2C—migraine	0.000131	0.00405	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HTR2B—migraine	0.000128	0.00395	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—EDNRA—migraine	0.000128	0.00394	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—HTR7—migraine	0.000127	0.00391	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CALCA—migraine	0.000123	0.00379	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—HTR7—migraine	0.000115	0.00355	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—LRP1—migraine	0.000113	0.00348	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—HTR2A—migraine	8.88e-05	0.00274	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NOTCH4—migraine	8.66e-05	0.00267	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HTR1B—migraine	8.35e-05	0.00257	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—HTR2A—migraine	8.07e-05	0.00248	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HTR1A—migraine	8.04e-05	0.00248	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TAC1—migraine	7.92e-05	0.00244	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NPS—migraine	7.92e-05	0.00244	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PGR—migraine	7.92e-05	0.00244	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HTR2C—migraine	7.77e-05	0.00239	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—EDNRA—migraine	7.56e-05	0.00233	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NOTCH3—migraine	7.36e-05	0.00227	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CALCA—migraine	7.27e-05	0.00224	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HTR7—migraine	6.8e-05	0.00209	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TGFBR2—migraine	5.86e-05	0.0018	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HTR2A—migraine	4.76e-05	0.00147	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CACNA1A—migraine	4.72e-05	0.00145	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ESR1—migraine	4.23e-05	0.0013	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—MTHFR—migraine	1.56e-05	0.00048	CbGpPWpGaD
